ARTICLE: Removing mutant mtDNA from cells

2-Deoxy-D-glucose couples mitochondrial DNA replication with mitochondrial fitness and promotes the selection of wild-type over mutant mitochondrial DNA
Boris Pantic, Daniel Ives, Mara Mennuni, Diego Perez-Rodriguez, Uxoa Fernandez-Pelayo, Amaia Lopez de Arbina, Mikel Muñoz-Oreja, Marina Villar-Fernandez, Thanh-mai Julie Dang, Lodovica Vergani, Iain G Johnston, Robert DS Pitceathly, Robert McFarland, Michael G Hanna, Robert W Taylor, Ian J Holt, Antonella Spinazzola
Nature Communications 12 1 (2021)

This is an exciting one! As we've discussed before, mitochondrial DNA (mtDNA) molecules exist in large populations in our cells, encoding vital machinery. Devastating diseases can result when a high proportion of a cell's mtDNA molecules are mutated, but cells can deal with a low proportion of mutant mtDNA. So, it'd be great if we had a way to decrease the proportion of mutant mtDNA in cells -- below the threshold for disease.

Perhaps we do! We recently played a supporting role in a project with Antonella Spinazzola and Ian Holt, looking at what happens when cells containing a mixture of mutant and normal mtDNA are treated with chemicals. They found that a molecule called 2DG (for short) slows down the replication of mutant mtDNA in cells. As mtDNA is constantly replicating, this preferential inhibition of mutant means that normal mtDNA comes to dominate the cellular population over time. We showed this population shifting over time in a variety of human cell lines and growth media, including several chosen to model in vivo behaviour.

The project showed that 2DG compromises mitochondrial respiration much more in mutant than in wildtype mitochondria. This is likely why mutant replication was so challenged -- poorly functioning mitochondria are less likely to replicate. Restricting glutamine and glucose together had the same effect (though is perhaps harder to achieve in a therapeutic context). 2DG is in trials for epilepsy treatment, so may represent a path to new therapies addressing mtDNA disease. There's a press release here with some more commentary.

ARTICLE: Social networks of plant mitochondria

Network analysis of Arabidopsis mitochondrial dynamics reveals a resolved tradeoff between physical distribution and social connectivity
Joanna M Chustecki, Daniel J Gibbs, George W Bassel, Iain G Johnston
Cell Systems 12 419 (2021)

We recently spent some time looking at a long-standing question in plant cell biology -- why do mitochondria move the way they do? Plant mitos look for all the world like cars in a city, moving along highways and speedily getting from place to place. We combined laser microscopy, video analysis, physical modelling, and network science to explore what benefits this motion might bring to the cell. It turns out, it allows mitochondria to have social lives! Through the "social network" of encounters between moving mitochondria, beneficial exchange of contents can occur, while their motion allows the cell to keep its population well spread. Here's a blog article from Jo explaining things more!

Read more...

... and also check out Jo's beautiful site!

Mitochondria are in yellow in the microscopy image; their "social network", describing their encounters, is overlaid in white. Cover of the month's Cell Systems issue.

ARTICLE: Corals to crops -- how life protects the plans for its cellular power stations

Avoiding organelle mutational meltdown across eukaryotes with or without a germline bottleneck
David M Edwards, Ellen C Røyrvik, Joanna M Chustecki, Konstantinos Giannakis, Robert C Glastad, Arunas L Radzvilavicius, Iain G Johnston
PLoS Biology 19 e3001153 (2021)

(this text is from a press release about the article)

An international team of researchers led by the University of Bergen has uncovered how organisms from crops to corals may avoid deadly DNA damage during evolution.

Our cells, and those of animals, plants and fungi, contain compartments that produce chemical fuel. These compartments contain their own DNA, which stores instructions for important cellular machinery. But this so-called oDNA (organelle DNA) can become mutated, corrupting the instructions and preventing cells making enough energy.

In humans and some other animals, a process called the “bottleneck” allows some offspring to inherit less mutated oDNA. This process needs mothers’ egg cells to develop early, like in humans, where a human girl is born with all her egg cells already formed. But other organisms, from plants to fungi, don’t develop these cells early – their flexible body plans mean that eggs are not “set aside” early in development.<\p>

“We wanted to know how these organisms might avoid inheriting mutations without a human-like bottleneck,” said Ellen Røyrvik, a geneticist on the research team, based at UiB.

The scientists used mathematical modelling to show that a process called gene conversion – the controlled overwriting of DNA – could in theory allow some offspring to inherit less mutant oDNA without requiring a bottleneck. Using genome data, they found machinery controlling this process in plants and fungi, but also in soft corals, sponges, and algae – all organisms without fixed body plans. They also found that this machinery was most active in the parts of plants that will end up producing the seeds of the next generation, suggesting that it is indeed used to allow some offspring to inherit fewer mutations.

Organisms without fixed body plans (including octocorals, sea pens, sponges, plants, and fungi) and with fixed body plans (including humans and many animals) may use different strategies to avoid the buildup of damage in their cellular "power stations." CREDIT: Gemma Lofthouse

“Taken together, it looks like organisms without a fixed body plan – plants, fungi, corals, sponges, algae – may have adopted gene conversion to deal with oDNA mutations,” said Iain Johnston, an associate professor in the Mathematics Institute at UiB, who led the research. “Humans and other animals can develop egg cells early and use a bottleneck; other organisms can use gene conversion instead.”

Going forward, the team plans to explore how this overwriting of oDNA causes other issues in the organisms that use it – including crop plants, where it can cause sterility. They are also exploring the broader question of why these compartments contain oDNA at all, given the risk of mutational damage.

ARTICLE: What makes mitochondria selfish, and when do selfish ones win?

MtDNA sequence features associated with ‘selfish genomes’ predict tissue-specific segregation and reversion, Nucleic Acids Research 48 8290 (202)

Mitochondria, the power stations of the cell, are in some senses like people in a company. The company needs several people to contribute if it is to survive. Some people may work hard and contribute lots to the company. Others may selfishly slack off and rely on others doing the work.

The cell needs mitochondria to produce ATP, the chemical that powers many important processes. But there is evidence that some mitochondria are more selfish, and some less so, than others. Unselfish mitochondria produce machinery which helps produce ATP. Selfish mitochondria prefer to replicate, copying their DNA and contributing less to the cell. Interestingly, at the molecular level, there is something like a "switch": a mitochondrion either takes steps to produce useful machinery, or takes steps that will help it replicate.

We were interested in why different mitochondria choose different positions of this switch, and what is a good "strategy" for mitochondria under different conditions. We built a simple model of this behaviour to understand it. Unsurprisingly, we found that selfish mitochondria -- favouring replication, and contributing less to the cell -- profilerate over unselfish ones in cells where there's little pressure to co-operate. As they replicate more, selfish mitochondria eventually come to dominate such cells. Where there is cellular pressure, however, unselfish mitochondria may win out. This is because cells full of selfish mitochondria won't perform adequately, and the whole cell and all its mitochondria will die -- leaving those cells with more unselfish mitochondria remaining.

What do we mean by "cellular pressure"? Well, if some type of cells never die, clearly the latter event can't happen, and we'd expect selfish mitochondria to win. If cells die regularly, perhaps there's more capacity to select those filled with unselfish mitochondria. We looked at different tissues where cells die with different rates, in mice where cells had two different types of mitochondrial DNA (mtDNA). We found a consistent pattern where one type of mtDNA proliferated in slow-dying cells and the other proliferated in fast-dying cells. Why different mtDNA types "win" in different tissues is a big question (which we've looked at before!), and it looks like this might help explain some of these differences.

(A) Sequence features may make different mtDNA types more "selfish" (favouring replication) or "unselfish" (favouring the production of useful machinery). (B) Our theory shows how, depending on cellular pressures, one or the other strategy can be favoured, leading to selection for one or the other mtDNA type.

We also asked what it is about a particular mtDNA sequence that might make it more or less selfish. Based on how mtDNA produces useful machinery, and how it replicates, we hypothesised that some features in the so-called "control region" of mtDNA may influence selfishness. Using sequence information, we found that these features tied quite neatly in with the observations in these mouse models, and also in (more limited) observations from human cells. While certainly not resolved, this picture suggests a link between sequence features of mtDNA, cellular selfishness, and proliferation differences across different tissues. You can read more (for free) in Nucleic Acids Research here.

ARTICLE: The inheritance of mtDNA

Regulation of mother-to-offspring transmission of mtDNA heteroplasmy
Ana Latorre-Pellicer, Ana Victoria Lechuga-Vieco, Iain G Johnston, Riikka H Hämäläinen, Juan Pellico, Raquel Justo-Méndez, Jose María Fernández-Toro, Cristina Clavería, Adela Guaras, Rocío Sierra, Jordi Llop, Miguel Torres, Luis Miguel Criado, Anu Suomalainen, Nick S Jones, Jesús Ruíz-Cabello, José Antonio Enríquez
Cell Metabolism 30 1120 (2019)

Mitochondrial DNA (mtDNA) is inherited from mothers to children. If two or more types of mtDNA exist in a cell, the cell is called "heteroplasmic". Mothers may carry a heteroplasmic mixture of different mtDNA types in each of their oocytes (egg cells), so a mixture of different types may be passed on to children. Different oocytes may have different mixtures -- for example, one cel may have 50% type A and 50% type B, and another may have 70% A and 30% B. 

The inheritance of heteroplasmy depends both on a complicated "bottleneck" (see here and here) and whether either type has some advantage over the other -- a question that is hotly debated. The mechanisms that shape the inheritance of mtDNA populations remain poorly understood, so it's hard to predict which offspring will inherit which mixture. It's often the case that a disease is caused by a particular mixture -- for example, over 60% of type B -- so this complex inheritance makes it hard to plan fertility treatments too.

In a new paper in Cell Metabolism, we looked at the inheritance and consequences of heteroplasmy in mice. Strikingly, we found that the presence of any heteroplasmy has generally negative consequences for the cell. This is perhaps surprising, given the above view that we normally need a certain amount of a dangerous mtDNA type to cause disease. But it does match a prediction that we recently made by mathematically considering how a cell must invest energy in controlling mixed mtDNA populations. Correspondingly, we found that regardless of how much type A and type B there is, having a heteroplasmic mixture challenges metabolism in the embryo, and affects how readily induced pluripotent stem cells (iPSCs) can be produced from cells.

Given that heteroplasmy is a challenge, it seems that cells have evolved mechanisms to sense and address the inheritance of heteroplasmy. In addition to the bottleneck, we found (as in our previous work) that cell-to-cell variance of heteroplasmy increased in oocytes with age -- which will have the eventual effect of reducing heteroplasmy. We also found that particular mtDNA types had a selective advantage through inheritance, and identified a set of genes that shape this advantage. Variability in the expression of these genes, and variability in metabolic factors, led to differences in the strength of selection.

Some key findings from this paper, and links to our previous work.

This work was exciting because it provided some insights into the mechanisms that shape mtDNA populations between generations -- but also because it validated several predictions that our theoretical work had proposed in the past:

• Increasing heteroplasmy variance with age (predicted here, observed here)
• MtDNA selection occurs at different developmental stages (as we found here and here)
• Mixed mtDNA populations challenge the cell (predicted here)
• Genes related to mitochondrial dynamics shape mtDNA genetic makeup (predicted here)

We're continuing this exciting collaboration and looking in more depth at the behaviour of mtDNA over time.

ARTICLES: Evolving cellular populations of mtDNA

Evolving mtDNA populations within cells
Iain G Johnston, Joerg P Burgstaller
Biochemical Society Transactions 47 1367 (2019)

and

Varied mechanisms and models for the varying mitochondrial bottleneck
Iain G Johnston
Frontiers in Cell and Developmental Biology 7 294 (2019)

We've recently written two review papers looking at the dynamics of mitochondrial DNA (mtDNA) in cells. As we've written about before, cells contain populations of hundreds or thousands of mtDNA molecules. These molecules replicate and degrade, so that over time, cellular populations of mtDNA change and evolve. The amount of disease-causing mutations, and the number and structure of mtDNA molecules, may all change as organisms develop and age, with different consequences.

The first article, in Biochemical Society Transactions, takes a broad look at how cellular mtDNA populations change over time, considering a range of organisms from humans and other animals to plants and fungi. We look at the different processes that change mtDNA populations, which include replication and degradation but may also include recombination (particularly in plants) and cell-to-cell exchange of mitochondria. The review particularly highlights the importance of understanding cell-to-cell variability in mtDNA populations -- as it only takes a few cells with lots of mutant mtDNA to cause disease, it's important to understand the statistics of mtDNA populations across cells. We review experiments and theory aiming to do so, including our recent work showing that cell-to-cell variability of mtDNA mutant load increases over time in a wide variety of circumstances.

The second article, in Frontiers in Cell and Developmental Biology, focuses on the so-called "mtDNA bottleneck", a process that shapes mtDNA populations in early mammalian development, and helps prevent the inheritance of mutant mtDNA. Specifically, mtDNA undergoes a "genetic bottleneck" between generations, meaning that mothers' egg cells, and offspring, often have dramatically different mtDNA populations. The review emphasises that this "genetic bottleneck" is an effective quantity, not a directly measurable observation, that arises from several physical processes, including but not limited to a "physical bottleneck" or mtDNA depletion during development. Different ways of modelling, analysing, and explaining the "genetic bottleneck" are reviewed, from human populations to mouse egg cells and Adélie penguins. We invest some time in trying to explain the different assumptions, symbols, and methods that researchers have used to quantify the bottleneck over the years. Again, the importance of understanding cell-to-cell variance in mtDNA populations is a core theme.

A. Different processes shaping mixed mtDNA populations inside cells. B. The "genetic bottleneck", increasing mtDNA variance between egg cells and offspring.  

Like all reviews, these articles don't have new results, but attempt to summarise existing knowledge and thinking on these topics. We hope that both papers provide some interesting insights, references, and (in the case of the bottleneck paper) visualisations that may help understand these often confusing topics.

ARTICLE: The cell's power station policies

Energetic costs of cellular and therapeutic control of stochastic mitochondrial DNA populations

Hanne Hoitzing, Payam A Gammage, Lindsey van Haute, Michal Minczuk, Iain G Johnston, Nick S Jones

PLoS Computational Biology 15 e1007023 (2019)

(Hanne's also written a post about this paper, you can read it here)

Our cells are filled with populations of mitochondrial DNA (mtDNA) molecules, which encode vital cellular machinery that supports our energy requirements. The cell invests energy in maintaining its mtDNA population, like us using electricity-powered tools to help maintain our power stations. Our cellular power stations can vary in quality (for example, mutations can damage mtDNA), and are subject to random influences. How should the cell best invest energy in controlling and maintaining its power stations? And can we use this answer to design better therapies to address damaged mtDNA?

In a new paper here in PLoS Computational Biology, we attempt to answer this question using mathematical modelling, linking with genetic experiments done by our excellent collaborators at Cambridge (Payam Gammage, Lindsey Van Haute and Michal Minczuk). We first expand a mathematical model for how diverse mtDNA populations within cells change over time – building new power stations and decommissioning old ones, under the “governance” of the cell. We then produce an “energy budget” for the cellular “society” – describing the costs of building, decommissioning, and maintaining different power stations, and the corresponding profits of energy generation.

We find some surprising results. First, it can get harder to maintain a good energy budget in a tissue (a collection of individual cellular “societies”) over time, even if demands stay the same and average mtDNA quality doesn’t change. This is because the cell-to-cell variability in mtDNA quality does increase, carrying with it an added energetic challenge. This increased challenge could be a contributing factor to the collection of problems involved in ageing.

An overview of our approach. A mathematical model for the processes and "budget" involved in controlling mtDNA populations makes a general set of biological predictions and explains gene-therapy observations

Next, we found that cells with only low-quality mtDNA can perform worse than cells with a mix of low- and high-quality mtDNA. This is because low-quality mtDNA may consume less cellular resource, although global efficiency is decreased. Linked to this, removal of low-quality mtDNA (decommissioning bad power stations) alone is not always the best strategy to improve performance. Instead, jointly elevating low- and high-quality mtDNA levels, avoiding this detrimental mixed regime, is the best strategy for some situations. These insights may help explain some of the negative effects recently observed in cells with mixed mtDNA populations.

Our theory suggests that mixed mtDNA populations may do worse than pure ones, even if the pure population is a low-functionality mutant. Image from Hanne's post here 

We identified how best to control cellular mtDNA populations across the full range of possible populations, and used this insight to link with exciting gene therapies where low-quality mtDNA is preferentially removed through an experimental intervention (using so-called “endonucleases” to cut particular mtDNA molecules). We found that strong, single treatments will be outperformed by weaker, longer-term treatments, and identified how the mtDNA variability we know is present can practically effect the outcome of these therapies. We hope that the principles found in this work both add to our basic understanding of ageing and mixed (“heteroplasmic”) mitochondrial populations, and may inform more efficient therapeutic approaches in the future. Iain, Hanne, Nick

ARTICLE: Tension and Resolution

Tension and resolution: dynamic, evolving populations of organelle genomes within plant cells
IG Johnston
Molecular Plant 12 764 (2019)

Mitochondria and chloroplasts are compartments in cells that power complex life. Both started out billions of years ago as independent organisms with complete genomes, that were acquired by ancestral cells. Since these endosymbioses, the genomes of mitochondria (mt) and chloroplasts (cp) have become stripped down. Modern mt and cp have lost lots of genes either completely or the “host” cell nucleus. Mt and cp now exist in dynamic populations within the cells of modern organisms. In plants and algae, the two co-exist, sharing responsibility for the energy balance of the organism – and hence ultimately powering and feeding life, including the human population.

Plant mt and cp populations are weird. Different plants and algae have very different mt and cp genomes – some huge (many megabases, several chromosomes in the case of some mt) and some tiny. Unlike the more familiar animal (and human) case, plant mt genomes readily recombine, mixing up their structures and genetic content within the cell. Both mt and cp move around plant cells rapidly – we’re not sure why, particular for mt. Again, unlike animal mt, neither plant mt not cp are particularly prone to meet up and fuse into big networks – they usually stay as individual compartments, except for short interactions. We do know that if we perturb the physical or genetic dynamics of organelles, the plant suffers – which we can sometimes exploit in breeding efficient crops.

 Populations of mitochondria (A green, B) and chloroplasts (A blue, C) moving in the plant cell

In a recent review article here in Molecular Plant, we reviewed current knowledge about these dynamics and speculated about what principles these populations of mt and cp may be responding to. We first asked why mt and cp may retain different sets of genes in different species – a question we’ve touched upon before here (blog). Retaining more genes in organelles may have the “pro” of making individual organelles more independent, and better at responding to demands (see John Allen’s CoRR hypothesis, e.g. here). But there’s the “con” that organelles are dangerous places, and genes retained there may be more subject to damage than in the safe haven of the nucleus. So individual plants may choose to retain mt and cp genes for dynamism, or shift them to the nucleus for robustness. Neither extreme is perfect – there are always pros and cons – leading to a tension to which different plants have selected different resolutions.

Pursuing this line, we next speculated that because plants are immobile (and hence unable to move away from challenging conditions), they may favour the “dynamism” side over the “robustness” side. This would explain why they often retain more organelle genes than motile organisms, but would also predict that they face a double challenge: (i) more organelle genes and (ii) exposure to more challenging environments, both of which may lead to genetic damage. This could be a reason why plant organelles undergo recombination – as a way of ameliorating genetic damage. But again, there are pros and cons: the “pro” of fixing genetic damage is balanced by the “con” of recombination mixing and confusing genetic structure. Perhaps this is why the physical behaviour of plant organelles is different to that in animals – keeping mt and cp separate may limit the amount of recombination that can take place, allowing the plant to control this second pro-con tradeoff.

 

(left) the proposed tension between robustness (i) and dynamism (ii). Perhaps plants are more (ii)-like because they need to respond to fluctuating conditions... because of their immobility (right) with hypothesised knock-on consequences.

All of these ideas are presented as hypotheses, and we proposed some ways that a combination of new experiment and theory can help make progress understanding these complex, vital systems in future. Watch this space! Iain

ARTICLE: Coupling mitochondrial physics and genetics

Mitochondrial Network State Scales mtDNA Genetic Dynamics
Juvid Aryaman, Charlotte Bowles, Nick S. Jones and Iain G. Johnston
Genetics Early online July 10, 2019; https://doi.org/10.1534/genetics.119.302423

Mitochondrial DNA (mtDNA) populations within our cells encode vital energetic machinery. MtDNA is housed within mitochondria, cellular compartments lined by two membranes, that lead a very dynamic life. Individual mitochondria can fuse when they meet, and fused mitochondria can fragment to become individual smaller mitochondria, all the while moving throughout the cell. The reasons for this dynamic activity remain unclear (we’ve compared hypotheses about them before here and here, with blog articles here). But what influence do these physical mitochondrial dynamics have on the genetic composition of mtDNA populations?

MtDNA populations can, naturally or as a result of gene therapies, consist of a mixture of different mtDNA types. Typically, different cells will have different proportions of, say, type A and type B. For example, one cell may be 20% type A, another cell may be 40% type A, and a third may be 70% type A. This variability matters because when a certain threshold (often around 60%) is crossed for some mtDNA types, we get devastating diseases.

We previously showed mathematically (blog) and experimentally (blog) that this cell-to-cell variability in mtDNA proportions (often called “heteroplasmy variance” and sometimes referred to via the “mtDNA bottleneck”) is expected to increase linearly over time. However, this analysis pictured mtDNAs as individual molecules, outside of their mitochondrial compartments. When mitochondria fuse to form larger compartments, their mtDNA is more protected: smaller mitochondria (and their internal mtDNA) are subject to greater degradation. More degradation means more replication, and more opportunities for the fraction of a particular type of mtDNA to change per unit time. In a new paper here in Genetics, we show (using a mathematical tour de force by Juvid) that this protection can dramatically influence cell-to-cell mtDNA variability. Specifically, the rate of heteroplasmy variance increase is scaled by the proportion of mitochondria that exist in a fragmented state. (It turns out that it's the proportion of itochondria that are fragmented that's important -- not whether the rate of fission-fusion is fast or slow).

This has knock-on effects for how the cell can best get rid of low-quality mutant mtDNA. In particular, if mitochondria are allowed to fuse based on their quality (“selective fusion”), we show that intermediate rates of fusion are best for removing mutants. Too much fusion, and all mtDNA is protected; too little, and good mtDNA cannot be sorted from bad mtDNA using the mitochondrial network. This mechanism could help explain why we see different levels of mitochondrial fusion in different conditions. More broadly, this link between mitochondrial physics and genetics (which we’ve also speculated about here (blog) and here) suggests one way that selective pressures and tradeoffs could influence mitochondrial dynamics, giving rise to the wide variety of behaviours that remain unexplained. Juvid, Nick, and Iain

ARTICLE: How mitochondria can vary, and consequences for human health

(cross-posted from Imperial Mitochondriacs)

Mitochondria are components of the cell which are involved in generating “energy currency” molecules called ATP across much of complex life. Since many mitochondria exist within single cells (often hundreds or thousands), it is possible for the characteristics of individual mitochondria to vary within cells, and within tissues. This variation of mitochondrial characteristics can affect biological function and human health.

Since mitochondria possess their own, small, circular, DNA molecules (mtDNA), we can split mitochondrial characteristics into two categories: genetic and non-genetic. In our review, we discuss a number of aspects in which mitochondria vary, from both genetic and non-genetic perspectives. 

In terms of mitochondrial genetics, the amount of mtDNA per cell is variable. When a cell divides, its daughters receive a share of its parents mtDNA, but the split isn’t precisely 50/50, so cell division can cause variability in the number of mtDNAs per cell. As mtDNAs are replicated and degraded over time, errors in the copying process may give rise to mtDNA mutations, which may spread throughout a cell. Factors such as: the total amount, the rate of degradation/replication, the mean fraction of mutants, and the extent of fragmentation in the mitochondrial network, can all influence how variable the fraction of mutated mtDNAs becomes through time (see here for a preview of some upcoming work on this topic). The total amount, and mutated fraction of mtDNAs, are implicated in diseases such as neurodegeneration, as well as the ageing process.

Apart from genetic variations, there are many non-genetic features of mitochondria which also vary within and between cells. Changes in mtDNA sequence can change the amino-acid sequence of the proteins encoded by mtDNA, causing structural changes in the molecular machines which generate ATP. The shape of the membranes of mitochondria are also highly variable, and respond to mitochondrial activity through quantities such as pH, where mitochondrial activity itself may depend on mtDNA sequence. The previous two examples (mitochondrial protein and membrane structure) demonstrate how the genetic state of mitochondria may influence their non-genetic characteristics. Mitochondrial non-genetic characteristics may also influence the genetic state: for instance, mitochondrial membrane potential can influence the probability of a mitochondria being degraded, along with its mtDNA.

The inter-dependence of genetic and non-genetic characteristics demonstrate the complex feedback loops linking these two aspects of mitochondrial physiology. We suggest here that, since changes in mitochondrial genetics occur more slowly than most physical aspects of mitochondrial physiology, understanding mitochondrial genetics may be especially important in explaining phenomena such as ageing, which appears to be closely related to mitochondrial heterogeneity. You can freely access our work, which has recently been published in Frontiers in Genetics, as “Mitochondrial Heterogeneity” https://www.frontiersin.org/articles/10.3389/fgene.2018.00718/full Juvid, Iain and Nick.

 

ARTICLE: Time marches on -- mitochondria, ageing, and disease

Burgstaller, J.P., Kolbe, T., Havlicek, V., Hembach, S., Poulton, J., Piálek, J., Steinborn, R., Rülicke, T., Brem, G., Jones, N.S. and Johnston, I.G. Large-scale genetic analysis reveals mammalian mtDNA heteroplasmy dynamics and variance increase through lifetimes and generations. Nature communications, 9 2488 (2018)

DNA in mitochondria, the powerhouses of the cell, is passed down from mother to child. But there are many mitochondria in each cell, and these mitochondria may have different genetic features. If a mother carries a mixture of mitochondrial DNA (mtDNA) types, this can make it hard to say which features their children will inherit. For mothers carrying a disease-causing mtDNA mutation, this makes family planning and clinical therapies challenging.

In particular, the role of a mother's age has long been a mystery. Is the probability of a child inheriting a particular mtDNA feature higher when mothers are younger or older? An answer to this question could help plan clinical strategies to improve fertility and prevent the inheritance of deadly mitochondrial disease.

To address this, we worked with our excellent collaborators with a combination of maths, statistics, and experiment. Our collaborators used cutting-edge technology to reveal the mixtures of mtDNA in the egg cells of mother mice at a wide range of ages, and in the litters of offspring the mothers produced. This experimental work was the largest-scale study of mammalian mtDNA that we're aware of, involving thousands of observations throughout lifetimes and between generations. In concert, we developed a mathematical model describing the changes to, and inheritance of, mtDNA from mother to offspring. We combined the model and data to learn how different biological processes affect mtDNA through and between generations.

Cells contain populations of mitochondria, and these populations change over time. In European mice, we observed how variability in these populations evolves as mammals age and reproduce. We found that older mother have more varied mitochondria and pass this variance on to their offspring -- of central importance in the inheritance of genetic disease. 

We found that the variability of mtDNA dramatically increased as mothers aged. This means that the probability of inheriting more extreme -- both lower and higher -- levels of a genetic feature increases for older mothers. We also found that different mtDNA mixtures were inherited in different ways - with some mtDNA types favoured for inheritance and some disfavoured. We used our findings to create a way to predict how the risk that offspring would inherit disease-causing mtDNA features changes over time. Moving forward, we're aiming to harness these powerful ways of using large datasets to describe and predict the dynamics of mtDNA inheritance in humans, and to learn what it is about these mtDNA types that predicts their evolution across generations. You can read the article for free in Nature Communications here.

ARTICLE: How cells adapt to progressive increase in mitochondrial mutation

Aryaman, J., Johnston, I.G. and Jones, N.S. Mitochondrial DNA density homeostasis accounts for a threshold effect in a cybrid model of a human mitochondrial disease. Biochemical Journal, 474 4019 (2017).

Mitochondria produce the cell's major energy currency: ATP. If mitochondria become dysfunctional, this can be associated with a variety of devastating diseases, from Parkinson's disease to cancer. Technological advances have allowed us to generate huge volumes of data about these diseases. However, it can be a challenge to turn these large, complicated, datasets into basic understanding of how these diseases work, so that we can come up with rational treatments.

We were interested in a dataset (see here) which measured what happened to cells as their mitochondria became progressively more dysfunctional. A typical cell has roughly 1000 copies of mitochondrial DNA (mtDNA), which contains information on how to build some of the most important parts of the machinery responsible for making ATP in your cells. When mitochondrial DNA becomes mutated, these instructions accumulate errors, preventing the cell's energy machinery from working properly. Since your cells each contain about 1000 copies of mitochondrial DNA, it is interesting to think about what happens to a cell as the fraction of mutated mitochondrial DNA (called 'heteroplasmy') gradually increases.  We used maths to try and explain how a cell attempts to cope with increasing levels of heteroplasmy, resulting in a wealth of hypotheses which we hope to explore experimentally in the future.

The central idea arising from our analysis of this large dataset is that cells seem to attempt to maintain the number of normal mtDNAs per cell volume as heteroplasmy initially increases from 0% mutant. We suggest they do this by shrinking their size. By getting smaller, cells are able to reduce their energy demands as the fraction of mutant mtDNA increases, allowing them to balance their energy budget and maintain energy supply = demand. However, cells can only get so small and eventually the cell must change its strategy. At a critical fraction of mutated mtDNA (h* in the cartoon above), we suggest that cells switch on an alternative energy production mode called glycolysis. This causes energy supply to increase, and as a result, cells grow larger in size again. These ideas, as well as experimental proposals to test them, are freely available in the Biochemical Journal "Mitochondrial DNA Density Homeostasis Accounts for a Threshold Effect in a Cybrid Model of a Human Mitochondrial Disease". Juvid, Iain and Nick

ARTICLE: Supply, demand, energy, and death

Mitochondrial heterogeneity, metabolic scaling and cell death
J Aryaman, H Hoitzing, JP Burgstaller, IG Johnston, NS Jones
BioEssays e201700001; doi:10.1002/bies.201700001 (2017)

•  The links between mitochondrial functionality and various aspects of cell physiology remain unclear; we combine recent experimental insights with mathematical modelling to produce quantitative hypotheses linking metabolism, cell proliferation, and mitochondria.

Cells need energy to produce functional machinery, deal with challenges, and continue to grow and divide -- these activities and others are collectively referred to as "cell physiology". Mitochondria are the dominant energy sources in most of our cells, so we'd expect a strong link between how well mitochondria perform and cell physiology. Indeed, when mitochondrial energy production is compromised, deadly diseases can result -- as we've written about before.

The details of this link -- how cells with different mitochondrial populations may differ physiologically -- is not well understood. A recent article shed new light on this link by looking at a measure of mitochondrial functionality in cells of different sizes. They found what we'll call the "mitopeak" -- mitochondrial functionality peaks at intermediate cell sizes, with larger and smaller cells having less functional mitochondria. The subsequent interpretation was that there is an “optimal”, intermediate, size for cells. Above this size, it was suggested that a proposed universal relationship between the energy demands of organisms (from microorganisms to elephants) and their size predicts the reduction in the function of mitochondria. Smaller cells, which result from a large cell having divided, were suggested to have inherited their parent's low mitochondrial functionality. Cells were predicted to “reset” their mitochondrial activity as they initially grow and reach an “optimal” size.

We were interested in the mitopeak, and wondered if scientifically simpler hypotheses could account for it. Using mathematical modelling, our idea was to use the observation that as a cell becomes larger in volume, the size of its mitochondrial population (and hence power supply) increases in concert. We considered that a cell has power demands which also track its volume, as well as demands which are proportional to surface area and power demands which do not depend on cell size at all (such as the energetic cost of replicating the genome at cell division, since the size of a cell's genome does not depend on how big the cell is). Assuming that power supply = demand in a cell, then bigger cells may more easily satisfy e.g. the constant power demands. This is because the number of mitochondria increases with cell volume yet the constant demands remain the same regardless of cell size. In other words, if a cell has more mitochondria as it gets larger, then each mitochondrion has to work less hard to satisfy power demand.

To explain why the smallest cells also have mitochondria which do not appear to work hard, we suggested that some smaller cells could be in the process of dying. If smaller cells are more likely to die, and if dying cells have low mitochondrial functionality (both of these ideas are biologically supported), then, by combining this with the power supply/demand picture above, the observed mitopeak naturally emerges from our mathematical model.

As an alternative model, we also suggested that the mitopeak could come entirely from a nonlinear relationship between cell size and cell death, with mitochondrial functionality as a passive indicator of how healthy a cell is. This indicates the existence of multiple hypotheses which could explain this new dataset.

A recent study has provided new data for the relationship between cell physiology and mitochondrial functionality. We have used mathematical modelling to suggest that a mixture of cellular power demand scaling, as well as cell death, could intuitively account for these new data. However, a nonlinear relationship between cell death and cell size could also account for these data, as well as a nonlinear relationship between mitochondrial functionality and cell size, as proposed by the original authors of the dataset. By integrating such a relationship between cell size and mitochondrial functionality into one of our existing models, we found that this “mitopeak” helps explain a wider set of cell physiological data. Using our model to highlight these competing hypotheses, we suggest future experiments to gather further support for these potential explanations.

Interestingly, we also found that the mitopeak could be an alternative to one aspect of a model we used some time ago to explain a different dataset, looking at the physiological influence of mitochondrial variability. Then, we modelled the activity of mitochondria as a quantity that is inherited identically by each daughter cell from its parent, plus some noise -- noting that this was a guess at the true behaviour because we didn't have the data to make a firm statement. We needed this relationship because observed functionality varied comparatively little between sister cells but substantially across a population. The mitopeak induces this variability without needing random inheritance of functionality, and may thus be the refined picture we've been looking for. These ideas, and suggestions for future strategies to explore the link between mitochondria and cell physiology in more detail, are in our new BioEssays article here. Juvid, Nick, and Iain.

ARTICLE: The maths of mitochondrial DNA

Evolution of Cell-to-Cell Variability in Stochastic, Controlled, Heteroplasmic mtDNA Populations

IG Johnston, NS Jones

The American Journal of Human Genetics 99 (5), 1150-1162 (2016)

• Vital populations of mtDNA are constantly evolving in our cells in response to random influences and control from the nucleus: we build a general mathematical theory describing this poorly-understood process and show that it predicts a wide range of existing experimental outcomes and gives us lots of new insights into biology and disease

Mitochondrial DNA (mtDNA) contains instructions for building important cellular machines. We have populations of mtDNA inside each of our cells -- almost like a population of animals in an ecosystem. Indeed, mitochondria were originally independent organisms, that billions of years ago were engulfed by our ancestor's cells and survived -- so the picture of mtDNA as a population of critters living inside our cells has evolutionary precedent! MtDNA molecules replicate and degrade in our cells in response to signals passed back and forth between mitochondria and the nucleus (the cell's "control tower"). Describing the behaviour of these population given the random, noisy environment of the cell, the fact that cells divide, and the complicated nuclear signals governing mtDNA populations, is challenging. At the same time, experiments looking in detail at mtDNA inside cells are difficult -- so predictive theoretical descriptions of these populations are highly valuable.

Why should we care about these cellular populations? MtDNA can become mutated, wrecking the instructions for building machines. If a high enough proportion of mtDNAs in a cell are mutated, our cells struggle and we get diseases. It only takes a few cells exceeding this "threshold" to cause problems -- so understanding the cell-to-cell distribution of mtDNA is medically important (as well as biologically fascinating). Simple mathematical approaches typically describe only average behaviours -- we need to describe the variability in mtDNA populations too. And for that, we need to account for the random effects that influence them.  

​In our cells, signals from the "control tower" nucleus lead to the replication (orange) and degradation (purple) of mtDNA. These processes affect mtDNA populations that may contain normal (blue) and mutant (red) molecules. Our mathematical approach -- extending work addressing a similar but simpler system -- describes how the total number of machines, and the proportion of mutants, is likely to behave and change with time and as cells divide.

In the past, we have used a branch of maths called stochastic processes to answer questions about the random behaviour of mtDNA populations. But these previous approaches cannot account for the "control tower" -- the nucleus' control of mtDNA. To address this, we've developed a mathematical tradeoff -- we make a particular assumption (which we show not to be unreasonable) and in exchange are able to derive a wealth of results about mtDNA behaviour under all sorts of different nuclear control signals. Technically, we use a rather magical-sounding tool called "Van Kampen's system size expansion" to approximate mtDNA behaviour, then explore how the resulting equations behave as time progresses and cells divide.

Our approach shows that the cell-to-cell variability in heteroplasmy (the potentially damaging proportion of mutants in a cell) generally increases with time, and surprisingly does so in the same way regardless of how the control tower signals the population. We're able to update a decades-old and commonly-used expression (often called the Wright formula) for describing heteroplasmy variance, so that the formula, instead of being rather abstract and hard to interpret, is directly linked to real biological quantities. We also show that control tower attempts to decrease mutant mtDNA can induce more variability in the remaining "normal" mtDNA population. We link these and other results to biological applications, and show that our approach unifies and generalises many previous models and treatments of mtDNA -- providing a consistent and powerful theoretical platform with which to understand cellular mtDNA populations. The article is in the American Journal of Human Genetics here and a preprint version can be viewed here. Iain

ARTICLE: Migration, mothers, mitochondria, and medicine

mtDNA diversity in human populations highlights the merit of haplotype matching in gene therapies

EC Røyrvik, JP Burgstaller, IG Johnston

Molecular Human Reproduction 22 (11), 809-817 (2016)

• The diversity of mtDNA in modern human populations may pose a challenge to gene therapies that aim to prevent the inheritance of deadly mtDNA disease; we use population and census data, and large-scale mtDNA sequence data, to assess this risk and suggest strategies to combat it.

Some mothers carry disease-causing mutations in their mitochondrial DNA (mtDNA), which can be passed on to their children. Amazing cutting-edge therapies are designed to avoid the inheritance of mutant mtDNA, by endowing a child with mtDNA from another woman (let's say Wilma) -- with no dangerous mutations -- instead of the mother's (let's say Miranda's) mtDNA. However, due to technical challenges in the implementation of these therapies, a small amount of the mother's mtDNA may remain in the child. If that initially small amount can become amplified -- say Miranda's mtDNA proliferates more quickly than Wilma's -- it may come to dominate cells in the child. Then the disease which the therapy attempted to avoid may become manifest -- as we've written about before. 

We have previously found, in mice, that the more different two mtDNA types are, the more likely one is to dominate over another. So if Miranda and Wilma have very different mtDNA, there's a good chance Miranda's might become amplified. But, although these effects are dramatic in natural mouse populations, we don't really know how likely this "winning" and "losing" was between human mtDNAs (as we'd see in the above therapies). Say Matilda and Wilma both come from London. How different will their mtDNA types likely be? And so, what is the risk that Matilda's mtDNA will beat Wilma's, potentially complicating therapies?

Human mtDNA varies by geography -- women from different parts of the world belong to different mtDNA "haplogroups". Some haplogroups are themselves very diverse, and some less so; haplogroups also differ from each other by varying degrees. So we needed to address two questions: (1) what are the likely mtDNA groups of women taken from a given region (say, Birmingham); and (2) how genetically different are two mtDNAs taken from these groups?

(left) Due to the history and evolution of human populations, some mtDNA types -- denoted here by letters -- are historically more common in different world regions. (right) Our analysis of large-scale sequence data tells us how genetically different two mtDNAs from randomly-sampled women from different ancestral backgrounds are likely to be (circle size). The more different, the more likely the therapies involving that pair of women will experience difficulties.

To answer these, we retrieved (from the NCBI database) over 7000 human mtDNA sequences, as well as information about the mtDNA makeup of pre-industrial different regions around the world, and census information about the UK's, London's, and Birmingham's ethnic makeup. We used this information to estimate the mtDNA makeup of modern human populations -- which have become highly mixed through migration in recent times. Using these estimates, we then simulated thousands of Matilda-Wilma pairings in specific regions around the world (including the UK, London, and Birmingham). We recorded the genetic differences between these simulated pairs of mtDNAs to see how different we may expect women from different regions to be. The results have just appeared in Molecular Human Reproduction here; a similar, pre-peer-review version can be viewed for free here.

We found that the size of genetic differences likely to arise when sampling pairs women from modern populations was around 20-80 SNPs (single nucleotide polymorphisms -- specific molecular differences in mtDNA). This level of difference was enough to lead to substantial segregation bias in mouse models, suggesting that unprincipled choice of Wilmas from the general population could be problematic. These large differences are in large part due to modern population mixing, with substantial mixing of African and Asian mtDNA in modern UK cities contributing to the diversity. We showed that "haplotype matching" -- checking that Wilma is genetically similar to Matilda -- decreases these differences and so decreases the likelihood of problems with therapies. We also created a preliminary chart to help this process, showing which human haplotypes are genetically similar to others -- hopefully this will both help scientific understanding and therapeutic implementation in this field. Iain and Ellen

ARTICLE: Controlling the control of our cellular power stations

Modulating mitochondrial quality in disease transmission: towards enabling mitochondrial DNA disease carriers to have healthy children

Alan Diot, Eszter Dombi, Tiffany Lodge, Chunyan Liao, Karl Morten, Janet Carver, Dagan Wells, Tim Child, Iain G Johnston, Suzannah Williams, Joanna Poulton

Biochem Soc Trans (in press) (2016)

• Dysfunctional mitochondria are recycled by the cell in a process that helps avoid disease; we summarise extending and provide new information about this process, and show -- agreeing with our mathematical theory -- that it can be modulated with drug treatments, providing potentially new therapeutic avenues.

Mitochondria -- a focus of our research -- are "power stations" in our cells that produce the energy we need to live. Like the power stations we build, mitochondria contain machines that work to produce this energy. They also contain the genetic "instructions" on how to build these machines, in the form of mitochondrial DNA (mtDNA). MtDNA can become mutated, spoiling these instructions, giving rise to dysfunctional machines and causing problems in our cells. Thankfully, our cells have systems that helps remove these mutant mtDNAs and recycle the bad machines that they've produced. One example is "mitophagy" (from mito-(chondria) and -phagy (eating)), as we've written about before.

Mitophagy uses "autophagosomes" to remove mtDNA from the cell, but it's hard to observe and measure: our understanding of the process, and how we may influence it to address diseases, is limited. In a recent paper, we summarise current understanding of mitophagy, particularly during early development (of importance for the inheritance of mtDNA diseases). As experiments and models explore the process in more detail, different types of mitophagy (progressing through different pathways) have been identified, as have fascinating "surges" of mitophagy at different developmental stages. In a new paper in Biochemical Society Transactions we discuss how these individual results are helping to build an overall picture of how mtDNA populations are controlled by cells.

Figure: single-cell microscopy determines how many autophagosomes (green), potentially recycling dysfunctional mitochondria, exist in cells during development. Drug treatments (lower row) can influence this number, potentially allowing us to control cellular mtDNA populations.

We also present some interesting preliminary results that may help us better understand, and control, mitophagy. Very soon after fertilisation, as an egg cell starts to divide, it seems that the amount of mtDNA in the growing embryo may decrease, rather more than previously reported. The experimental team, centred on Alan Diot, explored how many autophagosomes existed within cells during this process, and also showed that post-fertilisation treatment with drugs can affect the number of autophagosomes and hence the mtDNA populations in dividing cells (see figure). We've previously shown using mathematical modelling that decreasing mtDNA content may help avoid the inheritance of mtDNA diseases -- these new results highlight the feasibility of these potential new therapeutic strategies to address mtDNA disease inheritance. Iain